Baccine develops bacteria-based immunotherapy treatment to enhance anti-tumor immunity and provide better treatment options.
| Website | https://baccine.tech/ |
| Employees | 10 (6 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Immunotherapy, Cancer Immunotherapy, Cancer Treatment, Immuno-Oncology, Immune Response, Oncology, Biotechnology, Drug Development, Precision Medicine, Tumor Microenvironment, Pharmaceutical, Clinical Trials, Medical Research, Biopharma, Life Sciences, Healthcare |
| Competitors | PharmaJet, iBio, Inc., Seqirus, MedImmune, INOVIO Pharmaceuticals, Inc., Valneva, Vaxart, Inc., CureVac, Moderna Therapeutics, Novavax +28 more (view full list) |
Looking for a particular Baccine employee's phone or email?
Mark Hasleton is the CEO of Baccine.
6 people are employed at Baccine.